Recent News

• 03.26.2025 - Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
• 03.20.2025 - 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.20.2025 - Avalo Reports 2024 Financial Results and Recent Business Updates
• 02.24.2025 - Avalo Therapeutics to Participate in Upcoming Investor Conferences

Recent Filings

• 03.20.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.20.2025 - 8-K Current report
• 03.20.2025 - EX-99.1 EX-99.1
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.30.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.30.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.30.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.30.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.13.2025 - 8-K Current report
• 01.03.2025 - 3 Initial statement of beneficial ownership of securities